AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17207146 — intervention group
Group type: COMPARATOR
Intervention: Engerix-B
Number of subjects: 60
Study 15617591 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 50
Study 15617591 — intervention group
Group type: COMPARATOR
Intervention: Reoperation
Number of subjects: 50
Study 15617591 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities of daily living and work status
Number of subjects: 50
Study 12518489 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest SpinBrush Pro
Number of subjects: 26
Study 12518489 — intervention group
Group type: COMPARATOR
Intervention: Crest SpinBrush
Number of subjects: 26
Study 12518489 — intervention group
Group type: COMPARATOR
Intervention: Oral-B Battery
Number of subjects: 26
Study 12518489 — intervention group
Group type: COMPARATOR
Intervention: Colgate Motion
Number of subjects: 26
Study 12518489 — intervention group
Group type: COMPARATOR
Intervention: Oral-B 3-D Excel
Number of subjects: 26
Study 12518489 — intervention group
Group type: COMPARATOR
Intervention: Crest experimental toothbrush
Number of subjects: 26
Study 10354193 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified lifestyle intervention for 12 months
Number of subjects: 60
Study 10354193 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment by cardiologists and general practitioners
Number of subjects: 60
Study 7853578 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg mitomycin C
Number of subjects: 0
Study 7853578 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg doxorubicin
Number of subjects: 0
Study 7853578 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (no maintenance)
Number of subjects: 0
Study 7853578 — intervention group
Group type: EXPERIMENTAL
Intervention: Early instillations (for 6 or 12 months)
Number of subjects: 0
Study 7853578 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged treatment (either immediate or delayed)
Number of subjects: 0
Study 1960560 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiation therapy (RT) to all initially involved nodal sites (total dose of 2,000 cGy, with an optional boost of 1,000 cGy)
Number of subjects: 222
Study 1960560 — intervention group
Group type: COMPARATOR
Intervention: Partial or no radiation therapy
Number of subjects: 222
Study 6121683 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker drugs
Number of subjects: 0
Study 6121683 — intervention group
Group type: COMPARATOR
Intervention: Drug treatment for mild hypertension
Number of subjects: 0
Study 30921603 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation for 12 weeks
Number of subjects: 115
Study 30921603 — intervention group
Group type: COMPARATOR
Intervention: Control group with regular resistance exercise
Number of subjects: 115
Study 29188859 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 52
Study 29188859 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance (baseline tests)
Number of subjects: 52
Study 26307564 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive Life Planning (RLP) intervention
Number of subjects: 0
Study 26307564 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive Life Planning enriched with Contraceptive Action Planning (RLP+) intervention
Number of subjects: 0
Study 26307564 — intervention group
Group type: COMPARATOR
Intervention: Information only control group
Number of subjects: 0
Study 23684734 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical disgust induction using audio scripts
Number of subjects: 40
Study 23684734 — intervention group
Group type: EXPERIMENTAL
Intervention: Moral disgust induction using audio scripts
Number of subjects: 40
Study 21479818 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 L of clear liquids (group A; 92 patients)
Number of subjects: 291
Study 21479818 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mL of aqueous sodium phosphate (group B; 89 patients)
Number of subjects: 291
Study 21479818 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 L of polyethylene glycol electrolyte solution (group C; 92 patients)
Number of subjects: 291
Study 21479818 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 291
Study 19631705 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% beta‐glucan‐enriched bread (betaGB)
Number of subjects: 14
Study 17550132 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU + low-dose CDDP (n=75)
Number of subjects: 155
Study 17550132 — intervention group
Group type: COMPARATOR
Intervention: 5-FU (n=77)
Number of subjects: 155
Study 15530928 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-imposed driving rules
Number of subjects: 24
Study 10746493 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily regimen: sulfadiazine (1 g twice a day) + 25 mg pyrimethamine + 15 mg folinic acid daily; n = 58
Number of subjects: 124
Study 10746493 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice-weekly regimen: sulfadiazine (1 g thrice a week) + 50 mg pyrimethamine + 15 mg folinic acid thrice a week; n = 66
Number of subjects: 124
Study 10746493 — intervention group
Group type: EXPERIMENTAL
Intervention: Not taking antiretroviral therapy
Number of subjects: 124
Study 8930946 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Attainment Scaling (GAS)
Number of subjects: 15
Study 8930946 — intervention group
Group type: COMPARATOR
Intervention: Alzheimer's Disease Assessment Scale‐Cognitive Section
Number of subjects: 15
Study 8930946 — intervention group
Group type: COMPARATOR
Intervention: Global Deterioration Scale
Number of subjects: 15
Study 8930946 — intervention group
Group type: COMPARATOR
Intervention: Clinical Global Impression
Number of subjects: 15
Study 8930946 — intervention group
Group type: COMPARATOR
Intervention: Mini‐Mental State Exam
Number of subjects: 15
Study 1529149 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 800 mg five times daily for 5 days
Number of subjects: 100
Study 1529149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 3900362 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 30
Study 3900362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2447325 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitoxin
Number of subjects: 55
Study 2447325 — intervention group
Group type: COMPARATOR
Intervention: Control (off digitoxin)
Number of subjects: 55
Study 28956191 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of HSV-2 infection at enrolment
Number of subjects: 2750
Study 28956191 — intervention group
Group type: EXPERIMENTAL
Intervention: Young age, being unmarried, having a partner with other partners
Number of subjects: 2750
Study 27145828 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional periodontal therapy with Er,Cr:YSGG laser application (Group 2)
Number of subjects: 60
Study 27145828 — intervention group
Group type: COMPARATOR
Intervention: Conventional periodontal therapy (Group 1)
Number of subjects: 60
Study 25913687 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 33
Study 25913687 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn-soy blended flours (CSB)
Number of subjects: 33
Study 23821423 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation exercises (60 minutes, twice a week for 12 weeks)
Number of subjects: 70
Study 20498389 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg/d
Number of subjects: 254
Study 20498389 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg/d
Number of subjects: 254
Study 20498389 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 30 mg/d
Number of subjects: 254
Study 20498389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 19021006 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gr i.v. paracetamol infusion 15 minutes before induction (Group I)
Number of subjects: 90
Study 19021006 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. Paracetamol infusion started 15 minutes before the end of surgery (Group II)
Number of subjects: 90
Study 19021006 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group III)
Number of subjects: 90
Study 17233365 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine administered at 8-hour intervals postoperatively
Number of subjects: 72
Study 17233365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 12699480 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant Analysis (DA) with genetic variables only
Number of subjects: 256
Study 12699480 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant Analysis (DA) with all related factors (gene and environmental factors)
Number of subjects: 256
Study 12699480 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANN) with all factors
Number of subjects: 256
Study 12699480 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analysis of ANN inputs
Number of subjects: 256
Study 10882621 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin (2 ng/kg LPS)
Number of subjects: 30
Study 8938538 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of stainable hepatic iron
Number of subjects: 69
Study 8938538 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of stainable hepatic iron in hepatitis C
Number of subjects: 69
Study 1402014 — intervention group
Group type: EXPERIMENTAL
Intervention: B subunit‐killed whole cell (BS‐WC)
Number of subjects: 3285
Study 1402014 — intervention group
Group type: EXPERIMENTAL
Intervention: Killed whole cell only (WC)
Number of subjects: 3285
Study 1402014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3285
Study 3865492 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (Kefolor), 20 mg/kg body weight b.i.d. for 10 days
Number of subjects: 77
Study 3865492 — intervention group
Group type: COMPARATOR
Intervention: Untreated cases
Number of subjects: 77
Study 30308699 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking training with simultaneous cognitive demand (dual-task)
Number of subjects: 50
Study 30308699 — intervention group
Group type: COMPARATOR
Intervention: Control walking training without cognitive distraction
Number of subjects: 50
Study 29108736 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sucrose solution (2 mL of 88% sucrose)
Number of subjects: 82
Study 29108736 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 mL)
Number of subjects: 82
Study 26707252 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissucol(®) (fibrin glue)
Number of subjects: 60
Study 26707252 — intervention group
Group type: COMPARATOR
Intervention: No Tissucol(®) (control group)
Number of subjects: 60
Study 23377167 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-standardized predialysis SBP of 110 to 140 mm Hg
Number of subjects: 2000
Study 23377167 — intervention group
Group type: COMPARATOR
Intervention: Target-standardized predialysis SBP of 155 to 165 mm Hg
Number of subjects: 2000
Study 23739436 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptol and Neyromidin
Number of subjects: 0
Study 23739436 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 20620200 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDIUM sled velocity group
Number of subjects: 40
Study 20620200 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST sled velocity group
Number of subjects: 40
Study 20620200 — intervention group
Group type: COMPARATOR
Intervention: SLOW sled velocity group
Number of subjects: 40
Study 20620200 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVING trials
Number of subjects: 40
Study 19040446 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinbone augmentation with Bio-Gide membrane
Number of subjects: 93
Study 19040446 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinbone augmentation without Bio-Gide membrane
Number of subjects: 93
Study 19040446 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Oss augmentation with Bio-Gide membrane
Number of subjects: 93
Study 19040446 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined augmentation techniques
Number of subjects: 93
Study 19040446 — intervention group
Group type: COMPARATOR
Intervention: Control group (no augmentation techniques mentioned)
Number of subjects: 93
Study 16882639 — intervention group
Group type: EXPERIMENTAL
Intervention: Class-based exercise program (group A)
Number of subjects: 63
Study 16882639 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program (group B)
Number of subjects: 63
Study 12811710 — intervention group
Group type: EXPERIMENTAL
Intervention: Superactivated charcoal (SAC) 75 g administered orally as a slurry in 8 oz of apple juice 3 hours after acetaminophen ingestion
Number of subjects: 46
Study 12811710 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SAC administered)
Number of subjects: 46
Study 11154093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (PRX)
Number of subjects: 1756
Study 11154093 — intervention group
Group type: EXPERIMENTAL
Intervention: Entacapone (ENT)
Number of subjects: 1756
Study 11154093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide (PRG)
Number of subjects: 1756
Study 11154093 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole (ROP)
Number of subjects: 1756
Study 11154093 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone (TOL) 600 mg
Number of subjects: 1756
Study 11154093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1756
Study 8957270 — intervention group
Group type: EXPERIMENTAL
Intervention: Semilente insulin
Number of subjects: 15
Study 8957270 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 15
Study 1530675 — intervention group
Group type: EXPERIMENTAL
Intervention: Product 1 (20 mg nifedipine)
Number of subjects: 40
Study 1530675 — intervention group
Group type: COMPARATOR
Intervention: Product 2 (20 mg nifedipine)
Number of subjects: 40
Study 2862713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime (151 mg/kg every 8 hours for 12 days)
Number of subjects: 82
Study 2862713 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin and Carbenicillin (6.3 mg/kg gentamicin every 8 hours, 450 mg/kg carbenicillin every 6 hours for 10 days)
Number of subjects: 82
Study 2862713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 82
Study 2862713 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin and Carbenicillin
Number of subjects: 82
Study 31485965 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical weight management tools (partial meal replacements, recreation center vouchers, pharmacotherapy, commercial weight loss program vouchers, group behavioral weight loss program) for $5 or $10 monthly.
Number of subjects: 428
Study 31485965 — intervention group
Group type: EXPERIMENTAL
Intervention: On-treatment participants (those actively using the tools).
Number of subjects: 428
Study 31485965 — intervention group
Group type: COMPARATOR
Intervention: Registry-based comparators (usual care).
Number of subjects: 428
Study 29729171 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab infusions
Number of subjects: 38
Study 29729171 — intervention group
Group type: COMPARATOR
Intervention: 5-aminosalicylic acid (5-ASA)
Number of subjects: 38
Study 27461877 — intervention group
Group type: EXPERIMENTAL
Intervention: Inert cream applied on the right hand during verbal session
Number of subjects: 18
Study 27461877 — intervention group
Group type: EXPERIMENTAL
Intervention: Inert cream applied on the right hand during conditioning session
Number of subjects: 18
Study 27461877 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal suggestion to feel more pain
Number of subjects: 18
Study 27461877 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning (conditioning)
Number of subjects: 18
Study 23512770 — intervention group
Group type: EXPERIMENTAL
Intervention: UQDRIVE program (group education and support program)
Number of subjects: 131
Study 23512770 — intervention group
Group type: COMPARATOR
Intervention: Current clinical practice (no intervention)
Number of subjects: 131
Study 22884841 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 221
Study 22884841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 20026457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg plus dexamethasone 20 mg
Number of subjects: 285
Study 20026457 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 3 mg plus dexamethasone 20 mg
Number of subjects: 285
Study 18476957 — intervention group
Group type: EXPERIMENTAL
Intervention: Resiquimod 0.01%
Number of subjects: 132
Study 18476957 — intervention group
Group type: EXPERIMENTAL
Intervention: Resiquimod 0.03%
Number of subjects: 132
Study 18476957 — intervention group
Group type: EXPERIMENTAL
Intervention: Resiquimod 0.06%
Number of subjects: 132
Study 18476957 — intervention group
Group type: EXPERIMENTAL
Intervention: Resiquimod 0.1%
Number of subjects: 132
Study 15705084 — intervention group
Group type: EXPERIMENTAL
Intervention: Darifenacin 7.5 mg
Number of subjects: 395
Study 15705084 — intervention group
Group type: EXPERIMENTAL
Intervention: Darifenacin 15 mg
Number of subjects: 395
Study 15705084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395
Study 15705084 — intervention group
Group type: EXPERIMENTAL
Intervention: Darifenacin
Number of subjects: 395
Study 12571616 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician using mercury sphygmomanometer
Number of subjects: 106
Study 12571616 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician using Omron oscillometer
Number of subjects: 106
Study 12571616 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient using Omron oscillometer
Number of subjects: 106
Study 10472225 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam sedation
Number of subjects: 14
Study 10472225 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anaesthesia
Number of subjects: 14
Study 10472225 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sedation or anaesthesia)
Number of subjects: 14
Study 8551533 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular biofeedback therapy
Number of subjects: 38
Study 8551533 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise programs (post-therapy)
Number of subjects: 38
Study 1946881 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry face as CS+ (Conditioned Stimulus Positive) with shock as UCS (Unconditioned Stimulus)
Number of subjects: 30
Study 1946881 — intervention group
Group type: COMPARATOR
Intervention: Happy face as CS+ (Conditioned Stimulus Positive) with shock as UCS (Unconditioned Stimulus)
Number of subjects: 30
Study 6794796 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa treatment
Number of subjects: 123
Study 6794796 — intervention group
Group type: COMPARATOR
Intervention: Simple observation (Control)
Number of subjects: 123
Study 31613129 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong African American Families (SAAF) program, 7 sessions
Number of subjects: 472
Study 31613129 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong African American Families (SAAF) program, at least 5 of 7 sessions
Number of subjects: 472
Study 31613129 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 472
Study 28181738 — intervention group
Group type: EXPERIMENTAL
Intervention: High animal protein (AP) diet
Number of subjects: 44
Study 28181738 — intervention group
Group type: COMPARATOR
Intervention: High plant protein (PP) diet
Number of subjects: 44
Study 28181738 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (AP and PP)
Number of subjects: 44
Study 24750268 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy (10000-lux light box, 30 min in the morning, three times a week for 4 weeks)
Number of subjects: 65
Study 24750268 — intervention group
Group type: COMPARATOR
Intervention: Routine care without light therapy
Number of subjects: 65
Study 23803704 — intervention group
Group type: EXPERIMENTAL
Intervention: BHT‐3021 (0.3, 1.0, 3.0, and 6.0 mg)
Number of subjects: 80
Study 23803704 — intervention group
Group type: EXPERIMENTAL
Intervention: BHT‐3021
Number of subjects: 80
Study 23803704 — intervention group
Group type: COMPARATOR
Intervention: BHT‐placebo
Number of subjects: 80
Study 21995590 — intervention group
Group type: EXPERIMENTAL
Intervention: NOMAC/E2 (2.5 mg/1.5 mg) in a 24/4-day regimen
Number of subjects: 1591
Study 21995590 — intervention group
Group type: COMPARATOR
Intervention: DRSP/EE (3 mg/30 μg) in a 21/7-day regimen
Number of subjects: 1591
Study 19632409 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and standard postoperative care
Number of subjects: 90
Study 19632409 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 90
Study 16730170 — intervention group
Group type: EXPERIMENTAL
Intervention: 750-mg levofloxacin for 5 days
Number of subjects: 219
Study 16730170 — intervention group
Group type: COMPARATOR
Intervention: 500-mg levofloxacin for 10 days
Number of subjects: 219
Study 15323064 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan 20 mg/day
Number of subjects: 1777
Study 15323064 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan 40 mg/day
Number of subjects: 1777
Study 11251523 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (40 microg, nasal spray)
Number of subjects: 61
Study 11251523 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (75 mg, intramuscularly)
Number of subjects: 61
Study 11251523 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin and Diclofenac
Number of subjects: 61
Study 9406292 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 60
Study 9406292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 7618719 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheter threaded 3 cm into the epidural space
Number of subjects: 100
Study 7618719 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheter threaded 5 cm into the epidural space
Number of subjects: 100
Study 7618719 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheter threaded 7 cm into the epidural space
Number of subjects: 100
Study 2801591 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin with 18 mg Fe
Number of subjects: 2